A Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer and Breast Cancer

NCT05653752 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer
Breast Cancer

Interventions

DRUG: YL202

Sponsor

MediLink Therapeutics (Suzhou) Co., Ltd.

Collaborators

[object Object]